A股異動丨新研股份(300159.SZ)回吐4.43% 提示風險稱上半年淨利潤可能為虧損
格隆匯8月12日丨站上軍工風口,此前兩日連續漲停的新研股份(300159.SZ)今日回吐4.43%,報6.04元,總市值90億元。新研股份昨晚提示風險稱,公司的股票交易價格連續2個交易日收盤價格漲幅偏離值累計超過30%,屬於股票交易異常波動情況。公吿稱,2020年度公司實現營業收入11.04億元,同比減少11.62%,歸母淨利潤為虧損25.58億元;2021年第一季度公司實現營業收入1.067億元,歸母淨利潤為虧損4,396.11萬元,在2021年一季報中公司對2021年1-6月業績進行預測,預測上半年淨利潤可能為虧損。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.